In agreement with our findings, Zhou et al. have also indicated that the interaction between TRIM29 and β-catenin may be involved in lung cancer progression, probably through altering the expression of cyclin-dependent kinases (CDKs) (37). Here, TRIM29 is linked to lung carcinoma.